EYWA Pharma recalls 500mg Levetir: Foreign tablet found in some bottles
EYWA Pharma recalls 500mg Levetiracetam tablets due to foreign 1000mg tablets found in some 120-count bottles. Affected products contain specific lot numbers and manufacturing dates.
Lower-risk recall
Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.
Contact the company
What happened, in plain English
EYWA Pharma is recalling 500mg Levetiracetam tablets that may contain a foreign 1000mg tablet. This could cause incorrect dosing if taken without noticing the extra tablet. Read more at govinfonow.com/recall/36687-eywa-pharma-recalls-500mg-levetir-foreign-tablet-found-in-some.
Source Summary by GovInfoNow · govinfonow.com/recall/36687-eywa-pharma-recalls-500mg-levetir-foreign-tablet-found-in-some · Updated October 4, 2026 · FDA enforcement record: FDA #D-0109-2021
Cite this page
“EYWA Pharma recalls 500mg Levetir: Foreign tablet found in some bottles.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36687-eywa-pharma-recalls-500mg-levetir-foreign-tablet-found-in-some. Based on FDA recall #D-0109-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0109-2021%22&limit=1).
Why it’s dangerous
The recall found a 1000mg Levetiracetam tablet inside a 500mg bottle. If someone takes the tablet without noticing the extra tablet, they could take too much medication, which might cause side effects.
Who’s affected
People who have the 120-count bottle of 500mg Levetiracetam tablets with lot number LEV5019021A manufactured in India. Those who take the medication as prescribed are most at risk.
How to tell if you have this one
Check for the 120-count bottle labeled 500mg Levetiracetam Tablets, Rx only. Look for lot number LEV5019021A on the bottle. The product was manufactured in India and sold with specific expiration date.
- Brand
EYWA Pharma- Category
Drug
What to do — step by step
Check Your Product
Look for the lot number LEV5019021A on the bottle to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.9 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0109-2021 (November 10, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0109-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.